Aplidin
Showing 1 - 10 of 10
Prostate Cancer Trial in Ann Arbor, Seattle (Aplidin (plitidepsin))
Terminated
- Prostate Cancer
- Aplidin (plitidepsin)
-
Ann Arbor, Michigan
- +1 more
Nov 16, 2020
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Plitidepsin, Dexamethasone)
Completed
- Relapsed/Refractory Multiple Myeloma
-
Tuscaloosa, Alabama
- +81 more
Oct 21, 2020
Relapsed/Refractory Leukemia Trial in New Brunswick (Plitidepsin plus Cytarabine)
Terminated
- Relapsed/Refractory Leukemia
- Plitidepsin plus Cytarabine
-
New Brunswick, New JerseyThe Cancer Institute of New Jersey
Oct 11, 2018
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Trial in
Terminated
- Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
-
Lille, France
- +5 more
Dec 31, 2020
Advanced Solid Tumors, Lymphomas Trial in New Brunswick, Villejuif (Plitidepsin and Sorafenib, Gemcitabine and Plitidepsin)
Completed
- Advanced Solid Tumors
- Lymphomas
- Plitidepsin and Sorafenib
- Gemcitabine and Plitidepsin
-
New Brunswick, New Jersey
- +1 more
Jun 6, 2011
Multiple Myeloma Trial in Boston (Plitidepsin)
Completed
- Multiple Myeloma
-
Boston, MassachusettsJerome Lipper Multiple Myeloma Center - Dept of Medical Oncology
Dec 14, 2009